Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001193125-26-034625

Options or other derivatives

  • Chief Operating Officer acquired 376,629 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hensley Mark Earl · Chief Operating Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-01-30 Grant or award : show line 1 in the form Restricted Stock Units +188,315 188,315 D
2026-01-30 Grant or award : show line 2 in the form Performance Stock Units +188,314 188,314 D
Loading xslF345X05/ownership.xml…